InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. TGT

Go back to InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System
INSPIREMD, Inc. (NASDAQ: NSPR) Delayed: 0.73 --0 (-0%)
Previous Close $0.73    52 Week High $3.35 
Open $0.73    52 Week Low $0.07 
Day High $0.80    P/E N/A 
Day Low $0.72    EPS $-0.96 
Volume 121,613